EMAP-II/AIMP1 Protein, Mouse, Recombinant (His)

The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD.

规格	价格/CNY		数量
100 μg	￥ 2,360	5日内发货
500 μg	￥ 9,490	5日内发货
1 mg	￥ 15,800	5日内发货

规格

价格/CNY

货期

数量

100 μg

￥ 2,360

5日内发货

500 μg

￥ 9,490

5日内发货

1 mg

￥ 15,800

5日内发货

产品描述

种属	Mouse
表达系统	E. coli
标签	N-His
蛋白编号	P31230
别名	p43, SCYE1, HLD3, EMAP-II, AIMP1, EMAP-2
蛋白构建	Recombinant Mouse EMAP-II/AIMP1 Protein is expressed from E.coli with His tag at the N-Terminus. It contains Ala2-Lys310.[Accession \|P31230]
蛋白纯度	> 95% as determined by Tris-Bis PAGE
分子量	The protein has a predicted MW of 35.1 kDa. The protein migrates to 42-46 kDa based on Tris-Bis PAGE result.

内毒素	Less than 1EU per μg by the LAL method.
缓冲液	Supplied as 0.22μm filtered solution in 20mM Tris, 500mM NaCl, 10% Glycerol (pH 8.0).
存储	Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
运输方式	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
研究背景	The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD.